Emotional behavior and expression patterns of tyrosine hydroxylase and tryptophan hydroxylase in senescence-accelerated mouse (SAM) P6 mice

Behavioural Brain Research

Volumn 188, Issue 2, 2008, Pages 329-336

  Niimi, Kimie ^a,b   Takahashi, Eiki ^b   Itakura, Chitoshi ^b  

^a Brain Science And Life Technology Research Foundation   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Elevated plus maze test; Light dark exploration test; Marble burying test; Open field test; SAMP6; Tail suspension test; Tryptophan hydroxylase; Tyrosine hydroxylase

Indexed keywords

SERINE; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN STEM; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; EMOTION; EMOTIONAL DISORDER; ENZYME PHOSPHORYLATION; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE; SENILE OSTEOPOROSIS; WESTERN BLOTTING;

AGE FACTORS; AGING; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; EMOTIONS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HINDLIMB SUSPENSION; LOCOMOTION; MALE; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MODELS, ANIMAL; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 39149131032     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.11.014     Document Type: Article

References (32)

1. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109 (2002) 915-921
2. Cecci M., Khoshbouei H., and Morklak D.A. Modulatory effects of norepinephrine, acting on alpha 1 receptors in the central nucleus of the amygdala, on behavioral and neuroendocrine responses to acute immobilization stress. Neuropharmacology 43 (2002) 1139-1147
3. Chen H., Shoumura S., and Emura S. Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. Histol Histopathol 19 (2004) 677-685
4. Chida Y., Sudo N., Mori J., and Kubo C. Social isolation stress impairs passive avoidance learning in senescence-accelerated mouse (SAM). Brain Res 1067 (2006) 201-208
5. Flood J.F., and Morley J.E. Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22 (1998) 1-20
6. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 (1999) 397-401
7. Griffin W.S.T., Sheng J.G., and Mrak R.E. Senescence-accelerated overexpression of S100β in brain of SAMP6 mice. Neurobiol Aging 19 (1998) 71-76
8. Halbreich U., Rojansky N., Palter S., Hreshchyshyn M., Kreeger J., Bakhai Y., et al. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 57 (1995) 485-491
9. Harada W.-J., Haycock J.W., and Goldstein M. Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J Neurochem (1996) 629-635
10. Hill M.N., Karacabeyli E.S., and Gorzalka B.B. Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32 (2007) 350-357
11. Ichimaru Y., Egawa T., and Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 68 (1995) 65-70
12. Karasawa N., Nagatsu I., Sakai K., Nagatsu T., Watanabe K., and Onozuka M. Immunocytochemical study of catecholaminergic neurons in the senescence-accelerated mouse (SAM-P8) brain. J Neural Transm 104 (1997) 1267-1275
13. Kasai S., Shimizu M., Matsumura T., Okudaira S., Matsushita M., Tsuboyama T., et al. Consistency of low bone density across bone sites in SAMP6 laboratory mice. J Bone Miner Metab 22 (2004) 207-214
14. Kuhn D.M., Arthur Jr. R., and States J.C. Phosphorylation and activation of brain tryptophan hydroxylase: identification of serine-58 as a substrate site for protein kinase A. J Neurochem 68 (1997) pp. 2220-2203
15. Liu C.Z., Yu J.C., Cheng H.Y., Jiang Z.G., Li T., Zhang X.Z., et al. Spatial memory performance and hippocampal neuron number in osteoporotic SAMP6 mice. Exp Neurol 201 (2006) 452-460
16. Matsushita M., Tsuboyama T., Kasai R., Okumura H., Yamamuro T., Higuchi K., et al. Age-related changes in bone mass in the senescence-accelerated mouse (SAM). SAM-R/3 and SAM-P/6 as new murine models for senile osteoporosis. Am J Pathol 125 (1986) 276-283
17. Michelson D., Stratakis C., Hill L., Reynolds J., Galliven E., Chrousos G., et al. Bone mineral density in women with depression. N Engl J Med 335 (1996) 1176-1181
18. Miyamoto M., Kiyota Y., Yamazaki N., Nagaoka A., Matsuo T., Nagawa Y., et al. Age-related changes in learning and memory in senescence-accelerated mouse (SAM). Physiol Behav 38 (1986) 399-406
19. Miyamoto M., Kiyota Y., Nishiyama M., and Nagaoka A. Senescence-accelerated mouse (SAM): age-related reduced anxiety-like behavior in the SAM-P/8 strain. Physiol Behav 51 (1992) 979-985
20. Miyamoto M. Characteristics of age-related behavioral changes in senescence-accelerated mouse SAMP8 and SAMP10. Exp Gerontol 32 (1997) 139-148
21. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N., et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21 (2000) 1761-1767
22. Numata T., Saito T., Maekawa K., Takahashi Y., Saitoh H., Hosokawa T., et al. Bcl-2-linked apoptosis due to increase in NO synthase in brain of SAMP10. Biochem Biophys Res Commun 297 (2002) 517-522
23. Ofek O., Karsak M., Leclerc N., Fogel M., Frenkel B., Wright K., et al. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103 (2006) 696-701
24. Okuma Y., and Nomura Y. Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach. Jpn J Pharmacol 78 (1998) 399-404
25. 2 receptor ligands modulate the behaviour of mice in the elevated plus maze. Pharmacol Biochem Behav 49 (1994) 985-995
26. Shimada A. Age-dependent cerebral atrophy and cognitive dysfunction in SAMP10 mice. Neurobiol Aging 20 (1999) 125-136
27. Silva A.J., Elgersma Y., and Costa R. Molecular and cellular mechanisms of cognitive function: implications to psychiatric disorders. Biol Psychiatry 47 (2000) 200-209
28. Silva M.J., Brodt M.D., Ko M., and Abu-Amer Y. Impaired marrow osteogenesis is associated with reduced endocortical bone formation but does not impair peristeal bone formation in long bones of SAMP6 mice. J Bone Miner Res 20 (2005) 419-427
29. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
30. Takeda T., Hosokawa M., and Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol 32 (1997) 105-109
31. Zhuang X., Gross C., Santarelli L., Compan V., Trillat A.C., and Hen R. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology Suppl. 2 (1999) 52S-60S
32. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adiposic, and aphagic. Cell 83 (1995) 1197-1209